Patents by Inventor Andrew Garrison King

Andrew Garrison King has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of enhancing bioactivity of chemokines
    Publication number: 20040057925
    Abstract: The present invention provides method of increasing the biological activity of KC, gro-&agr;, gro-&bgr;, and gro-&ggr; proteins, truncated and modified proteins characterized by having biological activity at least 1 log better than the full-length protein, and pharmaceutical compositions containing same.
    Type: Application
    Filed: May 15, 2002
    Publication date: March 25, 2004
    Applicant: SmithKline Beecham Corporation
    Inventors: Louis Martin Pelus, Pradip Kumar Bhatnagar, Andrew Garrison King, Joanna Maria Balcarek
  • Method of mobilizing hematopoietic stem cells
    Patent number: 6447766
    Abstract: A method of mobilizing hematopoietic stem cells from the bone marrow to the peripheral circulation is provided by administering to an animal an effective amount of mature, modified or multimeric forms of KC, gro&bgr;, gro&agr;, or gro&ggr;.
    Type: Grant
    Filed: December 20, 1999
    Date of Patent: September 10, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: Louis Martin Pelus, Andrew Garrison King, Yanqiu Qian
  • Methods of enhancing bioactivity of chemokines
    Patent number: 6399053
    Abstract: The present invention provides a method for the treatment of bacterial, fungal, and viral infections by administering a truncated Gro&bgr;.
    Type: Grant
    Filed: December 20, 1999
    Date of Patent: June 4, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: Louis Martin Pelus, Pradip Kumar Bhatnagar, Andrew Garrison King, Joanna Maria Balcarek
  • Truncated gro and KC chemokines having enhanced bioactivity
    Patent number: 6080398
    Abstract: The present invention provides method of increasing the biological activity of KC, gro-.alpha., gro-.beta., and gro-.gamma. proteins, truncated and modified proteins characterized by having biological activity at least 1 log better than the full-length protein, and pharmaceutical compositions containing same.
    Type: Grant
    Filed: March 5, 1996
    Date of Patent: June 27, 2000
    Assignee: SmithKline Beecham Corporation
    Inventors: Louis Martin Pelus, Pradip Kumar Bhatnagar, Andrew Garrison King, Joanna Maria Balcarek